To be the preferred choice for patients and referral sources for superior, compassionate, community based cancer care in Florida; providing the most advanced cancer treatment, utilizing cutting edge technologies and research, in a setting where patients can be close to home, surrounded and supported by family and friends.
World-Class Cancer Care Close to Home
Founded in 1984, Florida Cancer Specialists & Research Institute (FCS) has built a national reputation for excellence that is reflected in exceptional and compassionate patient care, driven by innovative clinical research, cutting-edge technologies, and advanced treatments, including targeted therapies, genomic-based treatment, and immunotherapy. With over 250 physicians, 220 nurse practitioners and physician assistants and nearly 100 locations in our network, we are committed to providing world-class cancer care in community-based settings close to home.
We utilize a comprehensive, multidisciplinary approach to cancer treatment and care, combined with some of the most advanced therapies, cutting-edge technologies and a state-of-the-art clinical trials research program.
Our team includes well-respected physicians and highly trained staff who provide each patient with an individualized treatment plan. Our physicians are board-certified and consistently ranked nationally as Top Doctors by U.S. News & World Report. Trained in such prestigious medical schools and research institutes as Duke, Stanford, Harvard, Emory, M.D. Anderson, and Memorial Sloan-Kettering, the physicians of Florida Cancer Specialists provide leadership and consultation in many of the state's leading hospitals.
Access to National Clinical Trials
Recognized by the American Society of Clinical Oncology (ASCO) with a national Clinical Trials Participation Award, FCS offers patients access to more clinical trials than any private oncology practice in Florida. Our patients have access to ground-breaking therapies, in a community setting, and may participate in national clinical research studies of drugs and treatment protocols. In the past 4 years, the majority of new cancer drugs approved for use in the U.S. were studied in clinical trials with Florida Cancer Specialists participation prior to approval.
Through our partnership with Sarah Cannon, we are one of the largest clinical research organizations in the United States.
Often, FCS leads the nation in initiating research studies and offering ground-breaking new therapies to patients. 84% of new cancer drugs approved in 2016 for use in the U.S. were studied in clinical trials conducted with FCS participation prior to approval.
FCS serves patients on the Gulf Coast from Naples to Tallahassee, Central Florida and on the East Coast from Palm Beach County to Jacksonville.
Florida Cancer Specialists has built a national reputation for excellence that is reflected in exceptional and compassionate patient care, driven by innovative clinical research and cutting-edge technologies that help advance targeted treatments and genetically-based immunotherapies, and embodied by our outstanding team of highly-trained and dedicated physicians, clinicians and staff.